1-(biphenyl-4-ylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine

Catalog No. :
ACYUOG973
CAS No. :
946394-50-9
Molecular Formula :
C22H20F3N3O2S
Molecular Weight :
447.48

IUPAC Name:1-([1,1'-biphenyl]-4-ylsulfonyl)-4-(3-(trifluoromethyl)pyridin-2-yl)piperazine

1-(biphenyl-4-ylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$107.00Login to see priceInquiryInquiry
5mg95%$267.00Login to see priceInquiryInquiry
10mg95%$381.00Login to see priceInquiryInquiry
25mg95%$575.00Login to see priceInquiryInquiry
50mg95%$772.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(biphenyl-4-ylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine
IUPAC Name1-([1,1'-biphenyl]-4-ylsulfonyl)-4-(3-(trifluoromethyl)pyridin-2-yl)piperazine
Molecular FormulaC22H20F3N3O2S
Molecular Weight447.48
SMILESO=S(=O)(C=1C=CC(=CC1)C=2C=CC=CC2)N3CCN(C4=NC=CC=C4C(F)(F)F)CC3
InChI KeyONBIFHXEZPQLAZ-UHFFFAOYSA-N
SynonymPiperazine, 1-([1,1'-biphenyl]-4-ylsulfonyl)-4-[3-(trifluoromethyl)-2-pyridinyl]-;1-(biphenyl-4-ylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine;11β-HSD1-IN-14;11β-HSD1 inibitor 17
CAS No.946394-50-9

Synthetic Route by SureRoute

1. ACYUOG973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYUOG973 route product structure diagram
    ACYUOG973946394-50-9
Inquiry

2. ACYUOG973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACYUOG973 route product structure diagram
    ACYUOG973946394-50-9
Inquiry

Comments (0)